Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress
Authors:
- Chiara SfogliariniCSChiara Sfogliarini
- Camilla BernardinelliCBCamilla Bernardinelli
- Paola Antonia CorsettoPCPaola Antonia Corsetto
- Angela Maria RizzoAngela Maria Rizzo
- Franca CattaniFCFranca Cattani
- Maria Candida CestaMCMaria Candida Cesta
- Marcello AllegrettiMAMarcello Allegretti
- Sara Della TorreSara Della Torre
- Massimo LocatiMLMassimo Locati
- Elisabetta VegetoEVElisabetta Vegeto
Open Access
- 29 June 2026
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 201, 119708
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell'Istruzione e del Merito
- Università degli Studi di Milano
This publication has 74 references indexed in Scilit:
- AEBS inhibition in macrophages: Augmenting reality for SERMs repurposing against infectionsBiochemical Pharmacology, 2024
- Low‐level lysosomal membrane permeabilization for limited release and sublethal functions of cathepsin proteases in the cytosol and nucleusFEBS Open Bio, 2022
- Raloxifene as a treatment option for viral infectionsJournal of Microbiology, 2021
- Reciprocal interference between the NRF2 and LPS signaling pathways on the immune‐metabolic phenotype of peritoneal macrophagesPharmacology Research & Perspectives, 2020
- Antimicrobial resistance: A multifaceted problem with multipronged solutionsMicrobiologyopen, 2019
- A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomasJournal of Neuro-Oncology, 2015
- Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patientsFamilial Cancer, 2015
- Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II StudyPediatric Blood & Cancer, 2012
- Involvement of cathepsin B in the processing and secretion of interleukin‐1β in chromogranin A‐stimulated microgliaGlia, 2009
- Combination therapy with irinotecan and protein kinase C inhibitors in malignant gliomaCancer, 2003